Assessment of 213Bi-Anti-Egfr MAb Treatment Efficacy in Malignant Cancer Cells With [1-13C]pyruvate and [18F]FDG

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-44484-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Influence on [18F]FDG Uptake by Cancer Cells After Anti-Pd-1 Therapy in an Enforced-Immune Activated Mouse Tumor

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Diagnostic Efficacy of 18f-FDG PET/CT in Patients With Adrenal Incidentaloma

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Cervical Cancer - Staging and Restaging With 18f-FDG PET/CT

Revista da Associacao Medica Brasileira
Medicine
2019English

Metabolic Tumour Burden Measured by 18f-FDG PET/CT Predicts Malignant Transformation in Patients With Neurofibromatosis Type-1

PLoS ONE
Multidisciplinary
2016English

Role of 18F FDG PET in Differentiating Benign and Malignant Primary Bone Tumors

Bangladesh Journal of Nuclear Medicine
2015English

18f-FDG PET in Detecting Primary Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Simultaneous Breast Cancer and DLBCL Lymphoma — Role of PET/CT Examination With 18f-FDG and 18f-Fes

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2018English

EGFR Gene Copy Number Assessment From Areas With Highest EGFR Expression Predicts Response to Anti-Egfr Therapy in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy